期刊文献+

RBM5蛋白的RNA识别区在肿瘤细胞周期调控中作用的研究 被引量:1

Research on the role of RNA recognition motif domains of RBM5 protein in theregulation of tumor cell cycle
在线阅读 下载PDF
导出
摘要 为分析RNA识别区(RNA recognition motif,RRM)在RBM5蛋白调控肿瘤细胞周期中的作用,本研究利用低表达RBM5的A549细胞系构建了A549/Vector、A549/RBM5-WT、A549/RBM5-△RRM三种稳定细胞株,通过流式细胞术检测,发现仅有A549/RBM5-WT能显著阻滞细胞于G1期,说明RRM区是RBM5抑制细胞周期进程必不可少的区域.利用Western Blot检测细胞中cyclin A与Phospho-Rb(ser 795)的蛋白水平差异,证明了RBM5蛋白的RRM能够参与其介导的pRb去磷酸化以及抑制cyclin A表达,从而抑制细胞周期进程. In order to analyze the role of RNA recognition region(RRM) in the regulation of tumor cell cycle by RBM5 protein, three stable cell lines A549/Vector, A549/RBM5-WT, A549/RBM5-△RRM were constructed by using A549 cell line with low expression of RBM5. The phase of cell cycle analysis by Flow cytometry showed that only A549/RBM5-WT was arrested in G1 phase, indicating that the RRM region was essential for RBM5 to inhibit cell cycle progression. Using Western Blot to detect the difference between cyclin A and Phospho-Rb(ser 795), it was proved that RRM of RBM5 protein could participate in pRb dephosphorylation mediated by RBM5 and inhibit cyclin A expression, thus inhibiting cell cycle progression.
作者 王迪 吴传芳 WANG Di;WU Chuan-Fang(Departement of Functional Genome, College of Life Sciences, Sichuan University, Chengdu 610065, China)
出处 《四川大学学报(自然科学版)》 CAS CSCD 北大核心 2019年第3期531-536,共6页 Journal of Sichuan University(Natural Science Edition)
基金 国家自然科学基金(31300674)
关键词 RBM5 RNA识别区 流式细胞术 WESTERN BLOT 细胞周期 RBM5 RNA recognition motif domain Flow Cytometry Western Blot cell cycle
  • 相关文献

参考文献3

二级参考文献30

  • 1全国大肠病理研究协作组.全国大肠癌病理研究统一规范[C].杭州:浙江医科大学出版社,1982.150-20.
  • 2Soussi T, Bfiroud C. Assessing TP53 status in hu- man tumours to evaluate clinical outcome [J]. Nat Rev Cancer, 2001, 1 (3): 233.
  • 3Freed-Pastor W A, Prives C. Mutant p53.. one name, many proteins [J]. Genes Dev, 2012, 26 (12): 1268.
  • 4Ali A, Shah A S, Ahmad A. Gain-of-function of mutant p53: mutant p53 enhances cancer progres- sion by inhibiting KLF17 expression in invasivebreast carcinoma cells [J]. Cancer Lett, 2014, 354 (1) .. 87.
  • 5Subramanian M, Francis P, Bilke S, et al. A mu- tant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasis[J]. Onco- gene, 2014, 34(9): 1094.
  • 6Muller P A, Vousden K H. Mutant p53 in cancer: new functions and therapeutic opportunities [J]. Cancer Cell, 2014, 25(3): 304.
  • 7Repetto O, De Paoli P, De Re V, et al. Levels of Soluble E-Cadherin in Breast, Gastric, and Colorec- tal Cancers [J ]. Biomed Res Int, 2014, 9 (16) : 408047.
  • 8Gheldof A, Berx G. Cadherins and epithelial-to- mesenchymal transition [J]. Prog Mol Biol Transl Sci, 2013, 116: 317.
  • 9Hwang C I, Matoso A, Corney D C, et al. Wild- type p53 controls cell motility and invasion by dual regulation of MET expression [J]. PNAS, 2011, 108 (34).. 14240.
  • 10Sdek P, Ying H, Chang DL, et al. MDM2 pro- motes proteasome-dependent ubiquitin- independent degradation of retinohlastoma protein [J]. Mol Cell, 2005, 20(5).. 699.

共引文献5

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部